/
AngioDynamics is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. Our execution strategy is built on innovative R&D, clinical and…
The business is unprofitable at the operating level (-13.66% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 3.8% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$15M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$314M
▼ -3.8% YoY
Net Income (TTM)
-$31M
▲ +81.6% YoY
Op. Margin
-11.32%
▲ +49.7pp YoY
ROIC
-15.09%
▲ +31.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$2M
▲ +52.4% YoY
Op. Cash Flow (TTM)
$4M
▲ +64.0% YoY
Net Debt
-$30M
Net Cash Position
Cash & Equiv.
$38M
5Y CAGR: +2.1%
Continue Research